WallStreetZenWallStreetZen

NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for NBIX

Based on 16 analysts offering 12 month price targets for Neurocrine Biosciences Inc.
Min Forecast
$100.00-24.94%
Avg Forecast
$142.44+6.91%
Max Forecast
$200.00+50.12%

Should I buy or sell NBIX stock?

Based on 16 analysts offering ratings for Neurocrine Biosciences Inc.
Buy
Strong Buy
7 analysts 43.75%
Buy
3 analysts 18.75%
Hold
6 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NBIX stock forecasts and price targets.

NBIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-02-08
Mizuho
Bottom 13%
13
HoldMaintains$140.00+5.08%2024-02-08
Wells Fargo
Top 9%
92
HoldMaintains$140.00+5.08%2024-02-08
Goldman Sachs
Top 22%
79
Strong BuyMaintains$153.00+14.84%2024-01-25
Barclays
Top 21%
80
Strong BuyMaintains$150.00+12.59%2024-01-23Find out why
Stifel Nicolaus
Bottom 11%
11
Strong BuyMaintains$144.00+8.08%2023-12-18

1 of 2

Forecast return on equity

Is NBIX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is NBIX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NBIX revenue forecast

What is NBIX's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$2.2B+17.99%
Avg 2 year Forecast
$2.6B+35.87%
Avg 3 year Forecast
$3.0B+56.72%
NBIX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NBIX earnings growth forecast

How is NBIX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
54.49%
Industry
31.79%
Market
21.75%
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NBIX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NBIX revenue growth forecast

How is NBIX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
16%
Industry
9.09%
Market
10.27%
NBIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NBIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NBIX vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
NBIX$133.23$142.44+6.91%Buy
VTRS$11.10$11.00-0.90%Sell
RDY$71.31$80.00+12.19%Strong Buy
TEVA$13.18$14.43+9.48%Strong Buy
CTLT$55.96$55.42-0.97%Hold

Neurocrine Biosciences Stock Forecast FAQ

Is Neurocrine Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 16 Wall Street analysts covering (NASDAQ: NBIX) stock is to Buy NBIX stock.

Out of 16 analysts, 7 (43.75%) are recommending NBIX as a Strong Buy, 3 (18.75%) are recommending NBIX as a Buy, 6 (37.5%) are recommending NBIX as a Hold, 0 (0%) are recommending NBIX as a Sell, and 0 (0%) are recommending NBIX as a Strong Sell.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.

What is NBIX's revenue growth forecast for 2024-2026?

(NASDAQ: NBIX) Neurocrine Biosciences's forecast annual revenue growth rate of 16% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Neurocrine Biosciences's revenue in 2024 is $1,887,100,000.On average, 11 Wall Street analysts forecast NBIX's revenue for 2024 to be $221,567,059,011, with the lowest NBIX revenue forecast at $215,911,351,802, and the highest NBIX revenue forecast at $230,956,884,290. On average, 11 Wall Street analysts forecast NBIX's revenue for 2025 to be $255,143,970,869, with the lowest NBIX revenue forecast at $237,802,999,602, and the highest NBIX revenue forecast at $292,751,035,580.

In 2026, NBIX is forecast to generate $294,288,525,808 in revenue, with the lowest revenue forecast at $261,565,388,214 and the highest revenue forecast at $357,928,441,530.

What is NBIX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NBIX) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is NBIX's Price Target?

According to 16 Wall Street analysts that have issued a 1 year NBIX price target, the average NBIX price target is $142.44, with the highest NBIX stock price forecast at $200.00 and the lowest NBIX stock price forecast at $100.00.

On average, Wall Street analysts predict that Neurocrine Biosciences's share price could reach $142.44 by Apr 17, 2025. The average Neurocrine Biosciences stock price prediction forecasts a potential upside of 6.91% from the current NBIX share price of $133.23.

What is NBIX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NBIX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.